WHO expert group completes policy review of Covaxin

Hyderabad/ Mumbai | Updated on October 12, 2021

The stage is set for the technical review of Bharat Biotech’s Covaxin, with the World Health Organization’s policy expert group completing its evaluation of the Covid vaccine.

Giving details of the review meeting last week by the WHO’s Strategic Advisory Group of Experts (SAGE) on Immunisation, the agency said: “Bharat Biotech’s Covid vaccine (Covaxin) was reviewed by SAGE; a policy recommendation will be issued when the vaccine is Emergency Use listed by WHO.”

Representatives clarified that SAGE and the Technical Advisory Group (TAG) evaluate the same evidence on the vaccine, but from two different perspectives.

The TAG review of Covaxin is expected this week.

Also read p10

Published on October 12, 2021

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

  1. Comments will be moderated by The Hindu Business Line editorial team.
  2. Comments that are abusive, personal, incendiary or irrelevant cannot be published.
  3. Please write complete sentences. Do not type comments in all capital letters, or in all lower case letters, or using abbreviated text. (example: u cannot substitute for you, d is not 'the', n is not 'and').
  4. We may remove hyperlinks within comments.
  5. Please use a genuine email ID and provide your name, to avoid rejection.

You May Also Like